Search Results - Janet Addison

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    PERFUSE: a French non-interventional study of patients with inflammatory bowel disease receiving infliximab biosimilar SB2: a 12-month analysis by Yoram Bouhnik, Bruno Fautrel, Laurent Beaugerie, Anne-Laure Pelletier, Christine Martinez-Vinson, Ulrich Freudensprung, Amira Brigui, Janet Addison

    Published in Therapeutic Advances in Gastroenterology (2023-03-01)
    Get full text
    Article


  2. 2

    Premature morbidity and mortality associated with potentially undiagnosed familial hypercholesterolemia in the general population by Kausik K. Ray, Demetris Pillas, Savvas Hadjiphilippou, Kamlesh Khunti, Sreenivasa Rao Kondapally Seshasai, Antonio J. Vallejo-Vaz, David Neasham, Janet Addison

    Published in American Journal of Preventive Cardiology (2023-09-01)
    Get full text
    Article


  3. 3

    Correction: Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month D... by Bruno Fautrel, Yoram Bouhnik, Carine Salliot, Franck Carbonnel, Mathurin Fumery, Christophe Bernardeau, Yves Maugars, Mathurin Flamant, Fabienne Coury, Ben Braithwaite, Salima Hateb, Janet Addison, the PERFUSE investigators

    Published in Drugs - Real World Outcomes (2025-01-01)
    Get full text
    Article


  4. 4

    Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the... by Bruno Fautrel, Yoram Bouhnik, Carine Salliot, Franck Carbonnel, Mathurin Fumery, Christophe Bernardeau, Yves Maugars, Mathurin Flamant, Fabienne Coury, Ben Braithwaite, Salima Hateb, Janet Addison, the PERFUSE investigators

    Published in Drugs - Real World Outcomes (2024-10-01)
    Get full text
    Article


  5. 5

    A phase 3, randomized, double-blind, active-controlled clinical trial to compare BAT1806/BIIB800, a tocilizumab biosimilar, with tocilizumab reference product in participants with... by Xiaomei Leng, Piotr Leszczyński, Slawomir Jeka, Shengyun Liu, Huaxiang Liu, Malgorzata Miakisz, Jieruo Gu, Lali Kilasonia, Mykola Stanislavchuk, Xiaolei Yang, Yinbo Zhou, Qingfeng Dong, Marian Mitroiu, Janet Addison, Mourad F. Rezk, Xiaofeng Zeng

    Published in Arthritis Research & Therapy (2024-09-01)
    Get full text
    Article


Search Tools: